Pacific Biosciences of California Management
Management criteria checks 2/4
Pacific Biosciences of California's CEO is Christian O. Henry, appointed in Sep 2020, has a tenure of 3.58 years. total yearly compensation is $6.62M, comprised of 10.1% salary and 89.9% bonuses, including company stock and options. directly owns 0.11% of the company’s shares, worth $413.85K. The average tenure of the management team and the board of directors is 3.4 years and 11.2 years respectively.
Key information
Christian O. Henry
Chief executive officer
US$6.6m
Total compensation
| CEO salary percentage | 10.1% |
| CEO tenure | 3.6yrs |
| CEO ownership | 0.1% |
| Management average tenure | 3.4yrs |
| Board average tenure | 11.2yrs |
Recent management updates
Recent updates
These Analysts Think Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Sales Are Under Threat
Apr 25
It's Down 25% But Pacific Biosciences of California, Inc. (NASDAQ:PACB) Could Be Riskier Than It Looks
Apr 16Pacific Biosciences' Pivot: From Shareholder Dilution To Expansion And Leadership
Mar 19Pacific Biosciences: Strong Cash And Doubling Revenue Signal Investment Growth
Feb 08With A 34% Price Drop For Pacific Biosciences of California, Inc. (NASDAQ:PACB) You'll Still Get What You Pay For
Feb 01What You Can Learn From Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) P/S
Dec 18Does Pacific Biosciences of California (NASDAQ:PACB) Have A Healthy Balance Sheet?
Nov 13The Price Is Right For Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even After Diving 27%
Aug 28Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Trading At A 32% Discount?
Jul 31Is It Time To Consider Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?
Jul 06Pacific Biosciences of California (NASDAQ:PACB) Is Carrying A Fair Bit Of Debt
May 25Is Now The Time To Look At Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?
Mar 29Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Worth US$8.8 Based On Its Intrinsic Value?
Feb 26Time To Worry? Analysts Just Downgraded Their Pacific Biosciences of California, Inc. (NASDAQ:PACB) Outlook
Aug 08Pacific Biosciences: A Prime Candidate For My 'Bio Boom' Portfolio
Jul 27Is Pacific Biosciences of California (NASDAQ:PACB) Using Debt Sensibly?
Jul 11Pacific Biosciences Hit By Sentiment, But The Future Of Long-Read Sequencing Is Strong
Apr 05Is Pacific Biosciences of California (NASDAQ:PACB) Using Too Much Debt?
Feb 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$307m |
| Sep 30 2023 | n/a | n/a | -US$309m |
| Jun 30 2023 | n/a | n/a | -US$319m |
| Mar 31 2023 | n/a | n/a | -US$321m |
| Dec 31 2022 | US$7m | US$667k | -US$314m |
| Sep 30 2022 | n/a | n/a | -US$299m |
| Jun 30 2022 | n/a | n/a | -US$206m |
| Mar 31 2022 | n/a | n/a | -US$175m |
| Dec 31 2021 | US$3m | US$650k | -US$181m |
| Sep 30 2021 | n/a | n/a | -US$37m |
| Jun 30 2021 | n/a | n/a | -US$77m |
| Mar 31 2021 | n/a | n/a | -US$59m |
| Dec 31 2020 | US$13m | US$195k | US$29m |
| Sep 30 2020 | n/a | n/a | -US$46m |
| Jun 30 2020 | n/a | n/a | -US$51m |
| Mar 31 2020 | n/a | n/a | -US$53m |
| Dec 31 2019 | US$100k | n/a | -US$84m |
| Sep 30 2019 | n/a | n/a | -US$115m |
| Jun 30 2019 | n/a | n/a | -US$111m |
| Mar 31 2019 | n/a | n/a | -US$109m |
| Dec 31 2018 | US$88k | n/a | -US$103m |
Compensation vs Market: Christian O.'s total compensation ($USD6.62M) is above average for companies of similar size in the US market ($USD2.37M).
Compensation vs Earnings: Christian O.'s compensation has increased whilst the company is unprofitable.
CEO
Christian O. Henry (55 yo)
3.6yrs
Tenure
US$6,616,251
Compensation
Mr. Christian O. Henry, MBA, serves as Independent Director at CM Life Sciences III Inc. since April 07, 2021. He has been President and Chief Executive Officer at Pacific Biosciences of California, Inc. S...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.6yrs | US$6.62m | 0.11% $ 413.8k | |
| Chief Financial Officer | 3.6yrs | US$2.62m | 0.036% $ 134.3k | |
| Chief Operating Officer | 3.3yrs | US$6.56m | 0.10% $ 385.6k | |
| Chief Commercial Officer | 1.7yrs | US$5.80m | 0.032% $ 120.1k | |
| Co-Founder | 23.8yrs | US$466.76k | no data | |
| VP & Chief Accounting Officer | 2.9yrs | no data | 0.012% $ 43.5k | |
| Head of Investor Relations | no data | no data | no data | |
| General Counsel & Corporate Secretary | no data | no data | no data | |
| Chief People Officer | no data | no data | no data | |
| Senior Vice President of Research & Development | less than a year | US$1.48m | no data | |
| Senior Vice President of Manufacturing & Quality | no data | no data | no data | |
| VP of Finance & Treasurer | 13.9yrs | no data | no data |
3.4yrs
Average Tenure
52.5yo
Average Age
Experienced Management: PACB's management team is considered experienced (3.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 5.8yrs | US$6.62m | 0.11% $ 413.8k | |
| Independent Director | 20.3yrs | US$259.00k | 0.0069% $ 25.9k | |
| Independent Director | 11.6yrs | US$255.00k | 0% $ 0 | |
| Independent Chairman | 10.8yrs | US$297.00k | 0.040% $ 151.8k | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 15.3yrs | US$265.00k | 0% $ 0 | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Chairman of Scientific Advisory Board | 1.4yrs | no data | no data |
11.2yrs
Average Tenure
69yo
Average Age
Experienced Board: PACB's board of directors are seasoned and experienced ( 11.2 years average tenure).